Predicting survival times for neuroblastoma patients using RNA-seq expression profiles.
Biol Direct. 2018 May 30;13(1):11
Authors: Grimes T, Walker AR, Datta S, Datta S
Abstract BACKGROUND: Neuroblastoma is the most common tumor of early childhood and is notorious for its high variability in clinical presentation. Accurate prognosis has remained a challenge for many patients. In this study, expression profiles from RNA-sequencing are used to predict survival times directly.